Luiz Henrique Geraldo

Luiz Henrique Geraldo

Auto-generated profile, based on publicly available information

Luiz Henrique Geraldo

Laboratório de Biologia das Células Gliais, Instituto de Ciências Biomédicas, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 November 2014 in Frontiers in Cellular Neuroscience
Verified
Journal Article
Open access
PDF file
AFAnna Carolina Carvalho da Fonseca
Anna Carolina Carvalho da Fonseca
DMDiana Matias
Diana Matias
CGCelina Garcia
Celina Garcia
RARackele Amaral
Rackele Amaral
LGLuiz Henrique Geraldo
Luiz Henrique Geraldo
FLFlavia Regina Souza Lima
Flavia Regina Souza Lima
The blood-brain barrier (BBB), constituted by an extensive network of endothelial cells together with neurons and glial cells, including microglia, forms the neurovascular unit. The crosstalk between these cells guarantees a proper environment for brain function. In this context, changes in the endothelium-microglia interactions are associated with a variety of inflammation-related diseases in brain, where BBB permeability is compromised. Increasing evidences indicate that activated microglia modulate expression of tight junctions, which are essential for BBB integrity and function. On the other hand, the endothelium can regulate the state of microglial activation. Here, we review recent advances that provide insights into interactions between the microglia and the vascular system in brain diseases such as infectious/inflammatory diseases, epilepsy, ischemic stroke and neurodegenerative disorders.

1 February 2021 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
LGLuiz Henrique Medeiros Geraldo
Luiz Henrique Medeiros Geraldo
TSTania Spohr
Tania Spohr
RARackele Ferreira Do Amaral
Rackele Ferreira Do Amaral
AFAnna Carolina Carvalho da Fonseca
Anna Carolina Carvalho da Fonseca
CGCelina Garcia
Celina Garcia
FLFlavia Regina Souza Lima
Flavia Regina Souza Lima
Lysophosphatidic acid (LPA) is an abundant bioactive phospholipid, with multiple functions both in development and in pathological conditions. Here, we review the literature about the differential signaling of LPA through its specific receptors, which makes this lipid a versatile signaling molecule. This differential signaling is important for understanding how this molecule can have such diverse effects during central nervous system development and angiogenesis; and also, how it can act as a powerful mediator of pathological conditions, such as neuropathic pain, neurodegenerative diseases, and cancer progression. Ultimately, we review the preclinical and clinical uses of Autotaxin, LPA, and its receptors as therapeutic targets, approaching the most recent data of promising molecules modulating both LPA production and signaling. This review aims to summarize the most update knowledge about the mechanisms of LPA production and signaling in order to understand its biological functions in the central nervous system both in health and disease.

1 July 2022 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
LJLaurent Jacob
Laurent Jacob
JNJose de Brito Neto
Jose de Brito Neto
SLStephanie Lenck
Stephanie Lenck
CCCeline Corcy
Celine Corcy
FBFarhat Benbelkacem
Farhat Benbelkacem
JTJean-Leon Thomas
Jean-Leon Thomas
Meningeal lymphatic vessels (MLVs) were identified in the dorsal and caudobasal regions of the dura mater, where they ensure waste product elimination and immune surveillance of brain tissues. Whether MLVs exist in the anterior part of the murine and human skull and how they connect with the glymphatic system and extracranial lymphatics remained unclear. Here, we used light-sheet fluorescence microscopy (LSFM) imaging of mouse whole-head preparations after OVA-A555 tracer injection into the cerebrospinal fluid (CSF) and performed real-time vessel-wall (VW) magnetic resonance imaging (VW-MRI) after systemic injection of gadobutrol in patients with neurological pathologies. We observed a conserved three-dimensional anatomy of MLVs in mice and humans that aligned with dural venous sinuses but not with nasal CSF outflow, and we discovered an extended anterior MLV network around the cavernous sinus, with exit routes through the foramina of emissary veins. VW-MRI may provide a diagnostic tool for patients with CSF drainage defects and neurological diseases.

16 August 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
LGLuiz H. Geraldo
Luiz H. Geraldo
YXYunling Xu
Yunling Xu
LJLaurent Jacob
Laurent Jacob
LPLaurence Pibouin-Fragner
Laurence Pibouin-Fragner
RRRohit R Rao
Rohit R Rao
Thomas MathivetThomas Mathivet
Thomas Mathivet
SLIT2 is a secreted polypeptide that guides migration of cells expressing Roundabout 1 and 2 (ROBO1 and ROBO2) receptors. Herein, we investigated SLIT2/ROBO signaling effects in gliomas. In patients with glioblastoma (GBM), SLIT2 expression increased with malignant progression and correlated with poor survival and immunosuppression. Knockdown of SLIT2 in mouse glioma cells and patient-derived GBM xenografts reduced tumor growth and rendered tumors sensitive to immunotherapy. Tumor cell SLIT2 knockdown inhibited macrophage invasion and promoted a cytotoxic gene expression profile, which improved tumor vessel function and enhanced efficacy of chemotherapy and immunotherapy. Mechanistically, SLIT2 promoted microglia/macrophage chemotaxis and tumor-supportive polarization via ROBO1- and ROBO2-mediated PI3K-γ activation. Macrophage Robo1 and Robo2 deletion and systemic SLIT2 trap delivery mimicked SLIT2 knockdown effects on tumor growth and the tumor microenvironment (TME), revealing SLIT2 signaling through macrophage ROBOs as a potentially novel regulator of the GBM microenvironment and immunotherapeutic target for brain tumors.

9 October 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
LJLaurent Jacob
Laurent Jacob
LBLigia Simoes Braga Boisserand
Ligia Simoes Braga Boisserand
LGLuiz Henrique Medeiros Geraldo
Luiz Henrique Medeiros Geraldo
JNJose de Brito Neto
Jose de Brito Neto
Thomas MathivetThomas Mathivet
Thomas Mathivet
JTJean-Leon Thomas
Jean-Leon Thomas
Cranial lymphatic vessels (LVs) are involved in the transport of fluids, macromolecules and central nervous system (CNS) immune responses. Little information about spinal LVs is available, because these delicate structures are embedded within vertebral tissues and difficult to visualize using traditional histology. Here we show an extended vertebral column LV network using three-dimensional imaging of decalcified iDISCO+-clarified spine segments. Vertebral LVs connect to peripheral sensory and sympathetic ganglia and form metameric vertebral circuits connecting to lymph nodes and the thoracic duct. They drain the epidural space and the dura mater around the spinal cord and associate with leukocytes. Vertebral LVs remodel extensively after spinal cord injury and VEGF-C-induced vertebral lymphangiogenesis exacerbates the inflammatory responses, T cell infiltration and demyelination following focal spinal cord lesion. Therefore, vertebral LVs add to skull meningeal LVs as gatekeepers of CNS immunity and may be potential targets to improve the maintenance and repair of spinal tissues.

4 March 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
KBKevin Boyé
Kevin Boyé
LGLuiz Henrique Geraldo
Luiz Henrique Geraldo
JFJessica Furtado
Jessica Furtado
LPLaurence Pibouin-Fragner
Laurence Pibouin-Fragner
MPMathilde Poulet
Mathilde Poulet
AEAnne Eichmann
Anne Eichmann
Blood-brain barrier (BBB) integrity is critical for proper function of the central nervous system (CNS). Here, we show that the endothelial Unc5B receptor controls BBB integrity by maintaining Wnt/β-catenin signaling. Inducible endothelial-specific deletion of Unc5B in adult mice leads to BBB leak from brain capillaries that convert to a barrier-incompetent state with reduced Claudin-5 and increased PLVAP expression. Loss of Unc5B decreases BBB Wnt/β-catenin signaling, and β-catenin overexpression rescues Unc5B mutant BBB defects. Mechanistically, the Unc5B ligand Netrin-1 enhances Unc5B interaction with the Wnt co-receptor LRP6, induces its phosphorylation and activates Wnt/β-catenin downstream signaling. Intravenous delivery of antibodies blocking Netrin-1 binding to Unc5B causes a transient BBB breakdown and disruption of Wnt signaling, followed by neurovascular barrier resealing. These data identify Netrin-1-Unc5B signaling as a ligand-receptor pathway that regulates BBB integrity, with implications for CNS diseases.